Drug
Naproxen
Naproxen: highest development phase Approved, developed by Aurobindo, Dr. Reddy's, GlaxoSmithKline and others. 5 trial records tracked on RxWires.
- Highest phase
- Approved
- Developer
- Aurobindo, Dr. Reddy's, GlaxoSmithKline
Trials
| Drug | Phase | Indication |
|---|---|---|
| NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE COLD AND SINUS | Approved | |
| Naproxen NCT01231490 | Phase 2 | Osteoarthritis |
| Naproxen Tablets, 500 mg NCT00803764 | Phase 1 | Bioequivalency |
| Naproxen Tablets, 500 mg NCT00804401 | Phase 1 | Bioequivalency |
| Naproxen sodium NCT01052129 | Phase 1 | Healthy |
Latest
No recent events.
Follow Naproxen on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.